Newer products lead Sanofi-Aventis to growth in Japan
14 April 2009
Ian Haydock
Please Login to read the full article.
14 April 2009
Ian Haydock
ian.haydock@informa.com
Sanofi-Aventis still sees good potential for the growth of its business in Japan, driven in large part by new launches and line extensions for core cardiovascular products.
But the group is not ruling out targeted local acquisitions. "We are open to exploring any kind of partnerships to...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Sanofi results: Genzyme doesn't paper over cracks, as emerging markets top US and EU
- Portola raises $89 million to go it alone with betrixaban
- Daiichi Sankyo drops edoxaban for post-orthopaedic surgery VTE in the US and EU
- Halaven bags top premium as price listing clears the way for Japanese launch
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
